Netaholic...
What you say does not make sense...they are the biggest shareholder, if it hurts shareholders, it hurts them!
Fact is, creating interest prior to the run up is part of the seeding process...get the stock on the radars to create interest in the first place, rev up the volumes (they were probably buying initially...maybe via friendlies), then sell off some stock to increase the free float.
It is all about liquidity...and you will not get larger holders and thereby ongoing market interest with zip number of shares trading each day.
It seems a little brutal at the moment...but in my view the longer term outlook will be greatly enhanced.
This is a serious company in the making...and whilst I agree there would have been other alternatives available for the company to achieve the same goals, I dod believe the current process will ultimately result in the least amount of dilution for all shareholders.
My only fear of course, which I have previously stated, is that in conjuction with the current seeding process, they are holding down the price to arrange a placement to themselves to pay for the Elouera acquisition...clearly an issue at 30c would reap them more shares than an issue at 40c or higher?
Anyway...at the end of the day, they currently have less than 3m shares (and options) to go...so at least we can assume it will not go on for ever.
I agree with you however of how frustrating it all is...and frankly find it strange they would want GUJ to look so bad at this particular point in time considering the similar format of their sister company spin-off?
I guess if that is already a full book however, they would not be concerned about window dressing of GUJ?
Cheers!
- Forums
- ASX - By Stock
- GUJ
- sucked in and spat out
GUJ
gujarat nre resources nl
sucked in and spat out, page-6
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Currently unlisted public company.
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online